<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A genetically confirmed case of spinocerebellar <z:hpo ids='HP_0001251'>ataxia</z:hpo> type 3 (SCA 3), presenting with disabling foot <z:hpo ids='HP_0001332'>dystonia</z:hpo>, <z:hpo ids='HP_0009830'>peripheral neuropathy</z:hpo>, and minimal <z:hpo ids='HP_0001317'>cerebellar signs</z:hpo> is reported </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:hpo ids='HP_0001332'>dystonia</z:hpo> improved dramatically with <z:chebi fb="0" ids="15765">levodopa</z:chebi> treatment in the absence of additional parkinsonian feature </plain></SENT>
<SENT sid="2" pm="."><plain>A trial of <z:chebi fb="0" ids="15765">levodopa</z:chebi> for <z:hpo ids='HP_0001332'>dystonia</z:hpo> in SCA 3 may be of therapeutic benefit, at least in the initial stage of the disease </plain></SENT>
</text></document>